Mortality Assessment Technology

Mortality Assessment Technology (MAT) is a revolutionary scientific predictive mortality assessment tool from BioSignia. It uses a patented predictive analytics model to more accurately assess mortality risk and safely increase preferred risk categorizations using common underwriting data.

CSC and BioSignia have joined forces to make this powerful underwriting tool easily accessible for life insurance as well as reinsurance organizations. Coupling this innovative offering with CSC’s Trusted Cloud Services gets companies up and running quickly, enjoying the benefits of pay-per-use with virtually no startup costs.

Manage Complex Underwriting with Science
MAT uses advanced predictive technology and evidence-based medical science to provide quantitative mortality assessments consistently and objectively using input values that are routinely captured and assessed in medically underwritten applications.

To produce an accurate mortality estimate for each applicant, MAT evaluates health risk factors in a comprehensive fashion rather than evaluating them independently. MAT takes into account not only independent contributions to risk but also combined and cumulative contributions.

This unique predictive underwriting tool can be accessed with a Web browser or it can be integrated seamlessly with your existing new business systems. Additionally, MAT scores can be integrated into and aligned to work with your own specific underwriting guidelines.

Increase Market Share and Profitability
In a highly competitive market, MAT facilitates underwriting excellence and gives you confidence in your ability to safely assess risks. You’ll see improvements in:

• Risk classification
• Pricing accuracy for each individual applicant or insured
• Risk selection and risk avoidance capabilities
• Pricing differentiation
• Taken and lapse rates
• Persistency rates.